146 related articles for article (PubMed ID: 1868251)
1. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections.
Nemunaitis J; Meyers JD; Buckner CD; Shannon-Dorcy K; Mori M; Shulman H; Bianco JA; Higano CS; Groves E; Storb R
Blood; 1991 Aug; 78(4):907-13. PubMed ID: 1868251
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor.
Nemunaitis J; Shannon-Dorcy K; Appelbaum FR; Meyers J; Owens A; Day R; Ando D; O'Neill C; Buckner D; Singer J
Blood; 1993 Sep; 82(5):1422-7. PubMed ID: 8364195
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer.
Cole DJ; Sanda MG; Yang JC; Schwartzentruber DJ; Weber J; Ettinghausen SE; Pockaj BA; Kim HI; Levin RD; Pogrebniak HW
J Natl Cancer Inst; 1994 Jan; 86(1):39-45. PubMed ID: 8271281
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation.
Nemunaitis J; Buckner CD; Appelbaum FR; Higano CS; Mori M; Bianco J; Epstein C; Lipani J; Hansen J; Storb R
Blood; 1991 May; 77(9):2065-71. PubMed ID: 1902125
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.
Saleh MN; Khazaeli MB; Wheeler RH; Bucy RP; Liu T; Everson MP; Munn DH; Schlom J; LoBuglio AF
Cancer Res; 1995 Oct; 55(19):4339-46. PubMed ID: 7671245
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
[TBL] [Abstract][Full Text] [Related]
7. Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial.
Wan L; Zhang Y; Lai Y; Jiang M; Song Y; Zhou J; Zhang Z; Duan X; Fu Y; Liao L; Wang C
J Clin Oncol; 2015 Dec; 33(34):3999-4006. PubMed ID: 26392095
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials.
Schuening FG; Nemunaitis J; Appelbaum FR; Storb R
Bone Marrow Transplant; 1994; 14 Suppl 4():S74-7. PubMed ID: 7728131
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human macrophage colony-stimulating factor-induced thrombocytopenia in dogs.
Abrams K; Yunusov MY; Slichter S; Moore P; Nelp WB; Burstein SA; McDonough S; Durack L; Storer B; Storb R; Gass MJ; Georges G; Nash RA
Br J Haematol; 2003 May; 121(4):614-22. PubMed ID: 12752103
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human macrophage colony-stimulating factor reduces plasma cholesterol and carrageenan granuloma foam cell formation in Watanabe heritable hyperlipidemic rabbits.
Schaub RG; Bree MP; Hayes LL; Rudd MA; Rabbani L; Loscalzo J; Clinton SK
Arterioscler Thromb; 1994 Jan; 14(1):70-6. PubMed ID: 8274480
[TBL] [Abstract][Full Text] [Related]
11. Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation.
Nemunaitis J; Singer JW; Buckner CD; Durnam D; Epstein C; Hill R; Storb R; Thomas ED; Appelbaum FR
Blood; 1990 Jul; 76(1):245-53. PubMed ID: 2194592
[TBL] [Abstract][Full Text] [Related]
12. Clinical applications of recombinant macrophage-colony stimulating factor (rhM-CSF).
VandePol CJ; Garnick MB
Biotechnol Ther; 1991; 2(3-4):231-9. PubMed ID: 1845128
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation.
De Witte T; Gratwohl A; Van Der Lely N; Bacigalupo A; Stern AC; Speck B; Schattenberg A; Nissen C; Gluckman E; Fibbe WE
Blood; 1992 Mar; 79(5):1359-65. PubMed ID: 1536959
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation.
Lazarus HM; Rowe JM
Blood Rev; 1994 Sep; 8(3):169-78. PubMed ID: 7529606
[TBL] [Abstract][Full Text] [Related]
15. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation.
Klingemann HG; Eaves AC; Barnett MJ; Reece DE; Shepherd JD; Belch AR; Brandwein JM; Langleben A; Koch PA; Phillips GL
Clin Invest Med; 1990 Apr; 13(2):77-81. PubMed ID: 2191816
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human macrophage colony-stimulating factor on plasma cholesterol levels.
Stoudemire JB; Garnick MB
Blood; 1991 Feb; 77(4):750-5. PubMed ID: 1993217
[TBL] [Abstract][Full Text] [Related]
18. Improved efficacy of a microencapsulated macrophage colony stimulating factor and methotrexate in melanoma.
D'Souza MJ; Pourfarzib R
Drug Dev Ind Pharm; 1999 May; 25(5):583-90. PubMed ID: 10219526
[TBL] [Abstract][Full Text] [Related]
19. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
Zhao J; Zhao XY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
[TBL] [Abstract][Full Text] [Related]
20. rhGM-CSF after allogeneic bone marrow transplantation from unrelated donors: a pilot study of cyclosporine and prednisone as graft-versus-host disease prophylaxis.
Nemunaitis J; Anasetti C; Bianco JA; Hasen J; Singer JW
Leuk Lymphoma; 1993 Jun; 10(3):177-81. PubMed ID: 8220115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
